CRISPR Therapeutics AG (CRSP) are being closely watched by investors as the firm’s Mesa Adaptive Moving Average (MAMA) has moved above the Fractional Adaptive Moving Average (FAMA), indicating that a potential upward move might be forthcoming. The MESA Adaptive Moving Average, which was developed by John Ehlers, is a technical trend-following indicator which adapts to price movement “based on the rate change of phase as measured by the Hilbert Transform Discriminator”. This method of adaptation features a fast and a slow moving average so that the composite moving average swiftly responds to price changes and holds the average value until the next bar’s close. The author states that because the average’s fallback is slow, trading systems can be created with almost whipsaw-free trades.
Even extremely solid stocks can sometimes face setbacks. There is no shortage of news regarding publically traded companies, and investors often have the tricky job of deciding what information is worth taking a closer look at. Making trading decisions based on one piece of data may not be the optimal course of action. When there is negative information about a company, investors may be quick to sell without looking deeper into the numbers. On the flip side, investors may be super quick to buy on good news without fully researching the stock.
Interested traders may also be keeping an eye on the Williams Percent Range or Williams %R. Williams %R is a popular technical indicator created by Larry Williams to help identify overbought and oversold situations. Investors will commonly use Williams %R in conjunction with other trend indicators to help spot possible stock turning points. CRISPR Therapeutics AG (CRSP)’s Williams Percent Range or 14 day Williams %R currently sits at -74.29. In general, if the indicator goes above -20, the stock may be considered overbought. Alternately, if the indicator goes below -80, this may point to the stock being oversold.
Another technical indicator that might serve as a powerful resource for measuring trend strength is the Average Directional Index or ADX. The ADX was introduced by J. Welles Wilder in the late 1970’s and it has stood the test of time. The ADX is typically used in conjunction with the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI) to help spot trend direction as well as trend strength. At the time of writing, the 14-day ADX for CRISPR Therapeutics AG (CRSP) is noted at 43.82. Many technical analysts believe that an ADX value over 25 would suggest a strong trend. A reading under 20 would indicate no trend, and a reading from 20-25 would suggest that there is no clear trend signal.
Investors may use various technical indicators to help spot trends and buy/sell signals. Presently, CRISPR Therapeutics AG (CRSP) has a 14-day Commodity Channel Index (CCI) of -75.53. The CCI was developed by Donald Lambert. The assumption behind the indicator is that investment instruments move in cycles with highs and lows coming at certain periodic intervals. The original guidelines focused on creating buy/sell signals when the reading moved above +100 or below -100. Traders may also use the reading to identify overbought/oversold conditions.
Taking a look at other technical levels, the 3-day RSI stands at 31.77, the 7-day sits at 46.64 and the 14-day (most common) is at 56.03. The Relative Strength Index (RSI) is an often employed momentum oscillator that is used to measure the speed and change of stock price movements. When charted, the RSI can serve as a visual means to monitor historical and current strength or weakness in a certain market. This measurement is based on closing prices over a specific period of time. As a momentum oscillator, the RSI operates in a set range. This range falls on a scale between 0 and 100. If the RSI is closer to 100, this may indicate a period of stronger momentum. On the flip side, an RSI near 0 may signal weaker momentum. The RSI was originally created by J. Welles Wilder which was introduced in his 1978 book “New Concepts in Technical Trading Systems”.
Keeping an eye on Moving Averages, the 50-day is 53.15, the 200-day is at 45.50, and the 7-day is 68.01 for CRISPR Therapeutics AG (CRSP). Moving averages have the ability to be used as a powerful indicator for technical stock analysis. Following multiple time frames using moving averages can help investors figure out where the stock has been and help determine where it may be possibly going. The simple moving average is a mathematical calculation that takes the average price (mean) for a given amount of time.
Investors might be looking high and low for quality stocks that have fallen out of favor with the investing community. There are plenty of stocks that get continuous coverage from the big media outlets, but there are many others that may be hiding behind the scenes. Conducting thorough stock research can help the investor isolate certain stocks that might be ready for a near-term bounce. With the stock market still trading near record levels, investors will be looking for any opportunity to pounce on shares that might have been left behind for whatever reason.